These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 9132771)

  • 1. [Alprazolam in the treatment of anxiety disorders and mixed anxiety and depressive disorders. Results of multicenter clinical trial].
    Kiejna A; Małyszczak K; Rzewuska M; Sobucka K; Florkowski A; Rajewski A; Rajewska J; Wojtanowska M; Dabkowski M; Brzeziński R; Rybakowski J; Sep-Kowalikowa B; Gałuszko P; Nowicki Z
    Psychiatr Pol; 1996; 30(6):973-92. PubMed ID: 9132771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alprazolam in the treatment of neurotic anxiety.
    Kerry RJ; McDermott CM
    Pharmatherapeutica; 1983; 3(7):451-5. PubMed ID: 6142462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alprazolam in clinically anxious patients with depressed mood.
    Aden GC
    J Clin Psychiatry; 1983 Jan; 44(1):22-4. PubMed ID: 6130082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of alprazolam on the symptoms of anxiety and depression].
    Małyszczak K; Kiejna A
    Psychiatr Pol; 1997; 31(6):745-52. PubMed ID: 9515306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the usefulness and effectiveness of anxiolytic therapies in neoplastic diseases].
    Ziółko E; Knopik J; Bucior J; Foltyn W; Jastrzebska-Okoń K; Tomczyk A; Kempiński M
    Pol Merkur Lekarski; 2004 Jun; 16(96):561-4. PubMed ID: 15510897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and tolerance of alprazolam and bromazepam in flexible doses. Double-blind study in 119 ambulatory anxious patients].
    Ropert R; Bernes J; Dachary JM
    Encephale; 1987; 13(2):89-95. PubMed ID: 2885173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical use of sustained release of alprazolam: A naturalistic study].
    De La Gándara Martín JJ; Sanz Granado O; Varona Martínez A; Such P
    Actas Esp Psiquiatr; 1999; 27(3):191-7. PubMed ID: 10431062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alprazolam in the treatment of panic attack patients with and without major depression.
    Pyke RE; Kraus M
    J Clin Psychiatry; 1988 Feb; 49(2):66-8. PubMed ID: 3338978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alprazolam versus lorazepam in the treatment of anxiety: controlled clinical study].
    Bernardi F; Fossi L; Faravelli C; Corsini GU; Varricchio MC
    Riv Patol Nerv Ment; 1984; 105(1):1-13. PubMed ID: 6571441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alprazolam and diazepam in the treatment of generalized anxiety.
    Elie R; Lamontagne Y
    J Clin Psychopharmacol; 1984 Jun; 4(3):125-9. PubMed ID: 6145726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
    Jonas JM; Cohon MS
    J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division.
    Pasquini M; Biondi M; Costantini A; Cairoli F; Ferrarese G; Picardi A; Sternberg C
    Depress Anxiety; 2006; 23(7):441-8. PubMed ID: 16841345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alprazolam in older depressed inpatients.
    Pitts WM; Fann WE; Sajadi C; Snyder S
    J Clin Psychiatry; 1983 Jun; 44(6):213-5. PubMed ID: 6133850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective experience and attitudes towards participation in clinical trials among patients with anxiety disorders.
    Klein E; Malel D; Zilberman I; Lenox RH
    Isr J Psychiatry Relat Sci; 1997; 34(4):265-9. PubMed ID: 9409083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical trial of bromazepam. Thirty-four cases (author's transl)].
    Horseau C; Brion S
    Nouv Presse Med; 1982 May; 11(22):1741-3. PubMed ID: 6124948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
    Cohn JB
    J Clin Psychiatry; 1981 Sep; 42(9):347-51. PubMed ID: 6115853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.